Zobrazeno 1 - 10
of 203
pro vyhledávání: '"Catherine Lai"'
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-27 (2023)
Abstract Acute myeloid leukemia (AML) is the most common acute leukemia in adults. While survival for younger patients over the last several decades has improved nearly sixfold with the optimization of intensive induction chemotherapy and allogeneic
Externí odkaz:
https://doaj.org/article/e674120c7855472b9cb5970ceea03ee8
Autor:
Keith Pratz, Catherine Lai, Brian A. Jonas, Courtney Dinardo, Cat N. Bui, Rajesh Kamalakar, Jalaja Potluri, Wei-Han Chang, Rohini Sen, Thomas W Leblanc
Publikováno v:
HemaSphere, Vol 7, p e925140d (2023)
Externí odkaz:
https://doaj.org/article/c2d7a933cbe240418dc2b574c491f41c
Publikováno v:
eJHaem, Vol 3, Iss 1, Pp 301-313 (2022)
Abstract The natural history of patients with myelodysplastic syndrome (MDS) is dependent upon the presence and magnitude of diverse genetic and molecular aberrations. The International Prognostic Scoring System (IPSS) and revised IPSS (IPSS‐R) are
Externí odkaz:
https://doaj.org/article/2648363954a243749afc7c304250dcc5
Autor:
James L Gulley, Thomas Hughes, Jennifer L Marté, Katherine R Calvo, Meghali Goswami, Christopher S Hourigan, Gege Gui, Laura W Dillon, Katherine E Lindblad, Julie Thompson, Janet Valdez, Dong-Yun Kim, Jack Y Ghannam, Karolyn A Oetjen, Christin B Destefano, Dana M Smith, Hanna Tekleab, Yeusheng Li, Pradeep Dagur, Jaydira del Rivero, Joanna Klubo-Gwiezdzinksa, Catherine Lai
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/45b9aa3831424071877f408309fd9bea
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-20 (2019)
Abstract Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults, with an incidence that increases with age, and a generally poor prognosis. The disease is clinically and genetically heterogeneous, and recent advances have im
Externí odkaz:
https://doaj.org/article/effa2c5334b54307968e8f98cfd38f3d
Publikováno v:
Therapeutic Advances in Hematology, Vol 12 (2021)
Acute myeloid leukemia (AML) is an aggressive malignancy characterized by clonal proliferation of neoplastic immature precursor cells. AML impacts older adults and has a poor prognosis. Despite recent advances in treatment, AML is complex, with both
Externí odkaz:
https://doaj.org/article/ac454a99c1334ec2ae1a50c47a401008
Autor:
Lauren Hall-Lew, Claire Cowie, Stephen Joseph McNulty, Nina Markl, Shan-Jan Sarah Liu, Catherine Lai, Clare Llewellyn, Beatrice Alex, Nini Fang, Zuzana Elliott, Anita Klingler
Publikováno v:
Journal of Open Humanities Data, Vol 7 (2021)
The ongoing Lothian Diary Project consists of 125+ audio/video recordings collected since May 2020 from residents of Edinburgh and the Lothian counties in Scotland. The diaries comprise self-recorded monologues or semi-structured interviews in which
Externí odkaz:
https://doaj.org/article/b15469b888db48b18dcfe14b47013149
Autor:
Bogdan Popescu, Sheenu Sheela, Julie Thompson, Sophia Grasmeder, Therese Intrater, Christin B. DeStefano, Christopher S. Hourigan, Catherine Lai
Publikováno v:
Clinical Hematology International, Vol 2, Iss 1 (2019)
Therapy for those with relapsed or refractory acute myeloid leukemia is suboptimal. Studies have suggested that timed sequential salvage combination cytotoxic chemotherapy may be particularly useful for that indication. We report here a series of ten
Externí odkaz:
https://doaj.org/article/8895d7cf66054857a40a898735357bb1
Autor:
Hong Yuen Wong, Anthony D. Sung, Katherine E. Lindblad, Sheenu Sheela, Gregory W. Roloff, David Rizzieri, Meghali Goswami, Matthew P. Mulé, Nestor R. Ramos, Jingrong Tang, Julie Thompson, Christin B. DeStefano, Kristi Romero, Laura W. Dillon, Dong-Yun Kim, Catherine Lai, Christopher S. Hourigan
Publikováno v:
Frontiers in Oncology, Vol 8 (2019)
Measurable residual disease (MRD) testing after initial chemotherapy treatment can predict relapse and survival in acute myeloid leukemia (AML). However, it has not been established if repeat molecular or genetic testing during chemotherapy can offer
Externí odkaz:
https://doaj.org/article/fa6ebebba15a441496da6f117f43dcad
Autor:
Sheenu Sheela, Sawa Ito, Jeffrey R. Strich, Maura Manion, Celina Montemayor-Garcia, Hao-Wei Wang, Karolyn A. Oetjen, Kamile A. West, Austin J. Barrett, Mark Parta, Juan Gea-Banacloche, Steven M. Holland, Christopher S. Hourigan, Catherine Lai
Publikováno v:
Leukemia Research Reports, Vol 8, Iss C, Pp 4-6 (2017)
Disseminated Fusarium infection is associated with high mortality in immunocompromised patients. Patients with acute myeloid leukemia (AML) often have an extended duration of neutropenia during intensive induction chemotherapy, consolidation chemothe
Externí odkaz:
https://doaj.org/article/533f5c1509fe41648282b4e067751539